tiprankstipranks
Trending News
More News >

Global Bio-chem Advances Debt Restructuring with Equity Swap and Supplier Settlements

Story Highlights
  • Global Bio-chem completed a Debt-to-Equity-Swap, giving Suppliers PRC LLPs a 28.98% stake in Century Dacheng.
  • The company secured settlement agreements with 33 suppliers, expecting a net gain of HK$17.0 million.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Global Bio-chem Advances Debt Restructuring with Equity Swap and Supplier Settlements

Don’t Miss TipRanks’ Half-Year Sale

Global Bio-chem Technology Group Co. Ltd. ( (HK:0809) ) has issued an update.

Global Bio-chem Technology Group Co. Ltd. has announced the completion of a Debt-to-Equity-Swap Agreement, resulting in Suppliers PRC LLPs holding a 28.98% equity interest in Century Dacheng. The company is progressing with its Suppliers Debt Restructuring Arrangement, expected to conclude by the end of 2025, pending necessary approvals. Concurrently, the company has reached settlement agreements with 33 remaining suppliers involving a significant debt discount, resulting in a projected net gain of no less than HK$17.0 million. These strategic financial maneuvers are aimed at stabilizing the company’s financial position and enhancing its operational capabilities.

More about Global Bio-chem Technology Group Co. Ltd.

Global Bio-chem Technology Group Co. Ltd. is a company incorporated in the Cayman Islands, operating in the biotechnology industry. The company focuses on developing and providing biochemical products and solutions, with a market emphasis on leveraging technology for sustainable and innovative biochemical advancements.

Average Trading Volume: 4,170,266

Technical Sentiment Signal: Buy

Current Market Cap: HK$810.6M

For an in-depth examination of 0809 stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1